Transmissible Spongiform Encephalopathies
|
|
- Clare Charles
- 6 years ago
- Views:
Transcription
1 Cambridge Healthtech Institute s 12th Annual Final Agenda REGISTER BY JANUARY 11 th AND SAVE UP TO $200 Transmissible Spongiform Encephalopathies February 11-12, 2008 Sheraton Inner Harbor Hotel Baltimore, MD THE DEFINITIVE AMERICAN TSE MEETING Featuring New Data Emerging Concerns: De novo Formation of Prions Pathogenesis Detection Cell Cultures: From the Bench to the Bed Treatment, Removal, or Inactivation Lead Sponsoring Publications: Hear From These Leading Organizations Rocky Mountain Laboratories - NIH Case Western Reserve University Warwick University Neurological Institute Carlos Besta Amorfix Life Sciences R-Biofarm AG CJD Surveillance Unit - Edinburgh University of Milan University of California - San Francisco University of Maryland and VA Medical Center Istituto Superiore Di Sanita...and many others Cambridge Healthtech Institute, 250 First Avenue, Suite 300, Needham, Massachusetts Telephone: or toll-free in the U.S Fax:
2 February 11, 2008 CHI s Transmissible Spongiform Encephalopathies is the longest running meeting of its kind in the world. This 12 th Annual meeting will address the ongoing progress in the science of prion diseases, as well as the newest developments in the fields of pathophysiology, transmission, detection, removal/inactivation, treatment, and prevention. This conference will present the newest data on TSEs in the context of its application to the pharmaceutical, biological, environmental and device industries. Scientific Advisors: Larisa Cervenakova, M.D., Ph.D., Senior Scientist, Transmissible Diseases Department, Holland Laboratory, American Red Cross Suzette A. Priola, Ph.D., Senior Investigator, Chief, TSE/Prion Molecular Biology Section, Laboratory of Persistent and Viral Diseases, Rocky Mountain Laboratories, NIH Monday, February 11, :00 am Registration and Morning Coffee Emerging Concerns: De novo Formation of Prions 8:00 Welcome by Session Chairperson Paul W. Brown, M.D. 8:15 Ultra-Sensitive Prion Assays Based on Seeded Conversions of Recombinant Prion Protein Byron W. Caughey, Ph.D., Senior Investigator, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIH PrPSc can seed the conformational conversion and polymerization of normal protease-sensitive prion protein (PrP-sen). Soto and colleagues have shown that this seeding activity allows ultrasensitive detection of prions using cyclical sonicated amplification (PMCA) reactions and brain homogenate as a source of PrP-sen. Building on the PMCA approach, we have developed faster, simpler prion detection methods using recombinant PrP-sen (rprp-sen) which can discriminate normal hamster brain homogenates from scrapie brain homogenates containing <1 intracerebral lethal dose within 2-3 days. In periodically sonicated or shaken cell-free reactions, sub-femptogram equivalents of PrPSc seeded the conversion of rprp-sen into easily detected quantities of specific protease-resistant PrP fibrils. Diseased and normal hamsters were also distinguished using 2-μl of cerebral spinal fluid as seeds. The relative speed, simplicity, replicability and sensitivity of these reactions should facilitate both the development of practical prion assays and structural analyses of prion-seeded PrP polymers. 8:40 De Novo Formation of Purified Native Prions Nathan R. Deleault, Ph.D., Department of Biochemistry, Dartmouth Medical School To study the mechanism of prion formation biochemically, we conducted a series of serial Protein Misfolding Cyclic Amplification (spmca) reactions using purified native PrPC and synthetic polyanionic molecules as substrates. For the first time, we demonstrate that infectious, wild type prions can be: (1) propagated in vitro using purified substrates, and (2) generated de novo from non-infectious components. Furthermore, we have observed that polyanionic molecules are selectively incorporated into physical complexes with PrP during the formation of purified prions in vitro. 9:05 De novo Generation of Prion Infectivity in a Cell-Free System Joaquin Castilla, Ph.D., Assistant Professor, Department of Infectology, Scripps Research Institute-Florida Transmissible spongiform encephalopathies (TSEs) are a group of neurodegenerative disorders affecting both humans and animals. There is no available treatment or therapy for these fatal diseases. The infectious agent associated with TSEs (termed prion) appears to be composed uniquely of a protein, which is a conformationally-modified version (PrPSc) of the cellular prion protein (PrPC). The disease is propagated by the conversion of host PrPC into PrPSc induced by small quantities of PrPSc. Interestingly, prions occur in the form of different strains that show distinct biological and physicochemical properties. TSEs can have diverse origins, including genetic, sporadic (putatively spontaneous) and infectious. The occurrence of sporadic cases of prion diseases in humans and maybe in other species, i.e. atypical bovine spongiform encephalopathy (BSE) in European and USA cattle and atypical scrapie cases in sheep suggest that spontaneous prion diseases may happen infrequently but ubiquitously. However, there are no reported cases of spontaneously-occurring prion disease in experimental wild-type rodent models. We have used a novel technique, Protein Misfolding Cyclic Amplification (PMCA) to rapidly propagate prions in the test tube, using normal brain homogenate as substrate. Prions propagated in vitro are infectious in vivo and maintain their prion strain specificity. PMCA has been used to efficiently amplify a variety of prion strains from mouse, hamster, bank vole, deer, cattle, sheep and human. Therefore, to mimic spontaneous generation of infectivity in vitro becomes one of the most important challenges in the prion field. We show here, for the first time, the de novo generation of infectious prions from bank voles (Clethrionomys glareolus) starting with non-infectious brain homogenates. Several biochemically different prion strains were generated using two different wild-type vole genotypes. The de novo in vitro generated PrPSc was highly infectious after its inoculation in bank voles. We show an extensive characterization of this spontaneous phenomenon. 9:30 PMCA Amplification of Prion Amyloid without Amplification of Infectivity Robert G. Rohwer, Ph.D., Director, Molecular Neurovirology Laboratory, Veterans Affairs Medical Center; and Associate Professor of Neurology, School of Medicine, University of Maryland at Baltimore Employing the original protocol for PMCA developed by Soto and colleagues, we obtained a 16 to 32 fold amplification of PK resistant PrP as determined by two fold serial dilution to the starting concentration on Western blot. In comparison, there was no difference in titer, as measured by limiting dilution titration, between the frozen control, a sample that was incubated at 37 C without sonication and the sonicated sample that produced the amyloid amplification. The limiting dilution titration method is sufficiently sensitive to have detected even a 20% difference in titer between the samples. A two fold increase in titer would have caused the infection of nearly every animal at the limiting dilution and could not have been missed. If there is amplification of infectivity during PMCA, it must follow very different kinetics from the amyloid. 9:55 Silent Prions in Normal Brains Wen-Quan Zou, M.D., Ph.D., Assistant Professor, Neuropathology, Case Western Reserve University The co-existence of cellular prion protein (PrPC) and its pathological isoform (PrPSc) is a prerequisite for the pathogenesis of prion diseases. However, molecular mechanism of PrPSc formation in the spontaneous prion diseases including sporadic and familial forms remains poorly understood. Our recent studies indicate that in the uninfected brain there are small amounts of abnormal PrP species that may be involved in the pathogenesis of spontaneous prion diseases. 2
3 10:20 Discussion with all Session Speakers 10:40 Coffee Break, Poster and Exhibit Viewing Pathogenesis Chairperson: Larisa Cervenakova, M.D., Ph.D. 11:10 Accumulation of Prion Protein in the Brain That is Not Associated with Transmissible Disease Pedro Piccardo, M.D., Senior Investigator, OBRR / DETTD / LBPUA, FDA 11:35 High Levels of TSE Infectivity Can Be Associated with Little or No Detectable PrPSc in Vivo Rona Barron, Ph.D., Neuropathogenesis Unit, Roslin Institute and Royal (Dick) School of Veterinary Studies This work examines the relationship between TSE infectivity and the abnormal prion protein, PrPSc. In a mouse model of disease we have shown high titres of TSE infectivity in brain tissue which contains little or no PrP-res. We also found no evidence of other abnormal PrP isofoms such as PK-sen PrPSc. These data question the true relationship between PrPSc and TSE infectivity, and the current reliance on PrPSc as the sole diagnostic marker for TSE disease. 12:00 Conversion of the BASE Prion into the BSE Prion: The Origin of BSE? Fabrizio Tagliavini, Ph.D., Director, Division of Neurology 5 & Neuropathology, Neurological Institute Carlo Besta Twenty years after the identification of bovine spongiform encephalopathy (BSE), the origin of the causal agent is still unknown. This issue is of fundamental importance, since knowledge of the origin of the BSE agent is essential for prevention of future outbreak of the disease or variants thereof in cattle and other mammals. We carried out transmission studies with transgenic mice expressing bovine PrP and four lines of non-transgenic mice and found that an atypical form of spongiform encephalopathy of cattle, termed BASE or BSE-L, is caused by a prion strain distinct from that of classical BSE. Noteworthy, this newly characterized prion strain has the ability to convert into the classical BSE strain upon serial transmission to inbred mouse lines. According to these results, BASE--which is regarded as a sporadic form of prion disease in cattle--may be the origin of BSE, following conversion of the causal agent in an intermediate host. 12:45 Luncheon Technology Workshop (Sponsorship Available) or Lunch on Your Own 2:00 Sporadic CJD and Atypical BSE: Two Children of One Protein Maurizio Pocchiari, M.D., Director of Research, Virology, Istituto Superiore Di Sanita The identification of forms of TSE diseases in cattle caused by prion strains different from BSE has raised new concerns on the possibility that these novel agents might induce disease in humans with a phenotype resembling sporadic CJD. The analysis of the distribution of the different molecular subtypes of sporadic CJD might give some answers. 2:25 Variant CJD: Residual Uncertainties Robert Will, M.D., National CJD Surveillance Unit, Edinburgh, UK Mortality from variant CJD continues to decline, but concerns for public health persist. These are based on uncertainty on the population prevalence of infection, the incubation period of vcjd and the potential for further cases of secondary transmission. Information from epidemiology, molecular biology and transmission studies may provide new insights into these issues. 2:50 Panel Discussion Detection 3:05 Comments by Session Chairperson Byron W. Caughey, Ph.D., Senior Investigator, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIH 3:10 Biochemical Detection of Prions in Blood and Urine Claudio Soto, Ph.D., Professor, Neurology, University of Texas-Galveston 3:35 The Elusive Precursor of PrPSc Teresa Pinheiro, Ph.D., Professor, Biological Sciences, University of Warwick A key molecular event in prion diseases is the conversion of the cellular prion protein, PrPC, to the aberrant disease-associated state, PrPSc. The details of this molecular transformation are not fully understood, but it has been suggested that an intermediate on the normal folding pathway of PrPC may be recruited to form PrPSc. Using conventional analyses of folding transition data determined by fluorescence and circular dichroism, and novel phase diagram analyses, we present compelling evidence for the presence of an intermediate species on the folding pathway of PrP. This state is structurally close to the native state and upon incubation produces off-pathway aggregates. The results explain the difficulties in prion diagnosis and suggest possible new directions for test development. 4:00 Afternoon Refreshment Break, Poster and Exhibit Viewing 4:30 Detection of Blood Prions with Epitope Protection Technology Neil Cashman, M.D., Professor, Medicine, Amorfix Life Sciences In order to detect prions, an assay must distinguish between the normally folded prion protein PrPC and its aggregated disease-causing conformation PrPSc. We have developed a chemical means to differentiate between PrPC and PrPSc, called Epitope Protection technology. PrPC is selectively modified with short-lived and highly-reactive chemicals which modify selected amino acids in the protein. Such chemical modification efficiently blocks immunological epitopes on PrPC and leaves them unrecognizable to many PrP antibodies. PrP molecules within prion particles are protected from chemical modification, and can then be detected by conventional immunoassay after disaggregation of the sample. We now report detection of the very small concentration of PrPSc, which has been estimated in the low femtogram range per ml of infected blood. We have tested this methodology by screening blinded panels of vcjd brain and spleen material spiked into plasma, and we can reliably detect vcjd brain homogenate after diluting a 10% homogenate more than 105-fold into plasma. A high-throughput version of the assay has been developed and allows the processing of thousands of samples per day. 4:55 PrionScreen - All TSEs on a Plate Martin Mehl, Ph.D., Product Manager BSE, Marketing, R-Biopharm AG PrionScreen, the Roche Diagnostics last generation ELISA kit, provides the actual demands to identify all relevant typical and atypical TSEs from various species within the same assay. The overall changes in test kit requirements and the data of the recent EU approvals are summarized from the industries view. 5:20 Discussion with all Session Speakers 5:35 Networking Reception in the Exhibit Hall 6:40 Close of Day One 3
4 February 12, 2008 Tuesday, February 12, :30 am Morning Coffee Cell Cultures: From the Bench to the Bed 9:00 Comments by Session Chairperson Suzette Priola, Ph.D 9:05 Exploring Pathogenesis in Cell Culture Suzette A. Priola, Ph.D., Senior Investigator, Chief, TSE/Prion Molecular Biology Section, Laboratory of Persistent and Viral Diseases, Rocky Mountain Laboratories, NIH The early events that occur during TSE infection are largely unknown. Using a tissue culture system that enables us to exclusively track abnormal prion protein (PrPSc) during acute exposure of cells to TSE infectivity, we have studied the initial interaction between PrPSc and the cell. Our data suggest that early events during TSE infection may be largely strain and cell-type independent. Understanding the acute stages of TSE infection may provide new targets and strategies for TSE prevention and/or therapeutics as well as advance our knowledge of basic TSE pathogenesis. 9:30 Talk Title to Be Announced Larisa Cervenakova, M.D., Ph.D., Senior Scientist, Transmissible Diseases Department, Holland Laboratory, American Red Cross 9:55 Clearance and Prevention of Prion Infection in Cell Culture by Anti-PrP Antibodies Thomas M. Wisniewski, M.D., Professor, Neurology, Pathology and Psychiatry, New York University School of Medicine 10:20 Discussion with All Session Speakers 10:35 Coffee Break, Poster and Exhibit Viewing Treatment, Removal, or Inactivation Chairperson: Robert G. Rohwer, Ph.D., Director, Molecular Neurovirology Laboratory, Veterans Affairs Medical Center; and Associate Professor of Neurology, School of Medicine, University of Maryland at Baltimore 11:05 Anti-TSE Immunization in a Hamster Model Giorgio Poli, Professor, DVM, Veterinary Pathology, University of Milan Vaccination has been shown to be effective in mouse models for neurodegenerative conditions characterized by protein misfolding, such as Alzheimer s disease (AD) and Transmissible Spongiform Encephalopathies (TSEs) and many different immunogens and strategies of intervention have been proposed. Here we show that the immunization of hamster with a synthetic oligopeptides PrP , corresponding to the central part of hamster prion protein, prolonged the survival time (>23 days) in animals challenged with the 263K strain of scrapie agent. The immunized hamster mounted a specific, but weak, antibody response, and developed also a specific cellmediated response (as shown by proliferation assay on splenocytes). Moreover, the results obtained with RT-Real Time PCR showed an over-expression of mrna for GFAP and pro-inflammatory cytokines (TNF-a, IL-1β) in brain of infected controls compared to immunized animals and healthy controls, as well as an decrease in IL-10 expression. Increased survival after challenge was also associated with reduction of cerebral lesions, glial fibrillary acid protein (GFAP) and PrP deposition (both in brain and spleen). Our results indicate that a humoral and cell mediated immune response can slow down PrPres deposition and decrease neuroinflammation; nevertheless, it is conceivable that the vaccination can activate in peripheral organs specific different and interacting mechanisms, as observed in other scrapie mouse models. 11:30 Application of PRDT Affinity Binding Technology to a Reduction of Risk of TSE Transmission in the Blood and Biopharmaceutical Industry Luisa Gregori, Ph.D., Assistant Director MNV Laboratory and Assistant Professor University of Maryland, BREF, University of Maryland and VA Medical Center Transmissible spongiform encephalopathy (TSE) diseases are neurodegenerative illnesses that can be transmitted by blood transfusion. Precautionary measures against the spread of TSE through the blood supply have been implemented, but alone those measures are not sufficient. Pathogen Removal and Diagnostic Technologies, Inc. (PRDT) developed a new strategy based on the use of ligands derived from a combinatorial chemistry approach that specifically adsorb the TSE agent. After screening several million compounds, PRDT identified a ligand that when coupled in resin format reduced the TSE causative agent from blood to the limit of detection of a bioassay. This resin was incorporated into a prion reduction filter, the P-CAPTTM filter, manufactured by MacoPharma. The product has already demonstrated utility in reducing infectivity > 3log 10 (brain derived infectivity in red blood cell concentrate - RBC) and > 1.2log 10 (endogenous whole blood derived infectivity). 11:55 Differential Resistance of Prions Strains to Inactivation Kurt Giles, Ph.D., Assistant Adjunct Professor, Institute for Neurodegenerative Diseases, University of California San Francisco Understanding prion inactivation is essential for avoiding iatrogenic transmission of CJD via surgical instruments, and ensuring the safety of the food supply. Using a range of transgenic mouse models sensitive to naturally occurring and rodent-adapted prion strains, we have determined the difference in resistance to inactivation for a range of prion strains. By applying a set of rigorous statistical approaches we have produced the most comprehensive study of prion inactivation. 12:20 Closing Comments by Scientific Advisors 12:30 Close of Conference 4
5 Cambridge Healthtech Institute s 12th Annual Transmissible Spongiform Encephalopathies THE DEFINITIVE AMERICAN TSE MEETING Sponsoring Publications: Web Partners: Sponsor and Exhibitor Information Showcase your company s expertise, brand your solutions and develop revenue-generating opportunities with qualified decision-makers by Exhibiting or Sponsoring. Sponsorship packages are designed to achieve your business development and networking goals and objectives. Sponsorship benefits include pre-conference, at-conference and post-conference marketing efforts. The earlier you secure your sponsorship, the more opportunity for exposure. Numerous promotional and sponsorship programs exist and are flexible to allow any size company to participate. Sponsored speaking opportunities may include: Technology Spotlight, embedded within the conference program Breakfast or Luncheon Workshops, allow for podium time Embedded Presentations Other sponsorship opportunities include sponsoring an Invite-Only VIP dinner to access this audience at the highest level, and ensure optimum face-to-face networking. Hotel Information Sheraton Inner Harbor Hotel 300 S. Charles Street Baltimore, MD Tel: Fax: Room Rate: $169 s/d Reservation Cutoff: January 11, 2008 Car Rental Information Special discount rentals have been established with AVIS for this conference. Please call AVIS directly at and you must reference your Avis Worldwide Discount (AWD) Number J For more information, to reserve booth space, or discuss sponsorships contact: Katelin Martin, kmartin@healthtech.com Call for Posters Reasons You Should Present Your Research Poster at Transmissible Spongiform Encephalopathies: Your poster will be exposed to our international delegation Receive $50 off your registration Your poster abstract will be published in our conference CD Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutes 5 Photo Credit: Dr. Al Jenny, 2003 (Content Providers(s): U.S. Dept. of Agriculture - Animal and Plant Health Inspection Service, APHIS)
6 Cambridge Healthtech Institute s 12th Annual Transmissible Spongiform Encephalopathies February 11-12, 2008 Sheraton Inner Harbor Hotel Baltimore, MD YES! Register me for Transmissible Spongiform Encephalopathies REGISTRATION INFORMATION Mr. Ms. Mrs. Dr. Prof. Name Job Title Div./Dept. Company Address City/State/Postal Code Country Telephone Would you like to receive event updates via fax? Yes No Fax * * is not a mandatory field. However, by excluding your you will not receive notification about online access to pre-conference presenter materials, conference updates and networking opportunities. PRICING INFORMATION COMMERCIAL ACADEMIC, GOVERNMENT, HOSPITAL AFFILIATED TWO DAY CONFERENCE REGISTER 3 4 th IS FREE Individuals must register for the same conference or conference combination and submit completed registration forms together for discount to apply. Please reproduce this registration form as needed Advanced Registration until January 11, 2008 $1195 $620 Registration after January 11, 2008 or On-Site $1395 $695 Poster Discount $50 Off $50 Off I cannot attend but would like to purchase the Transmissible Spongiform Encephalopathies conference CD for $250 (plus shipping). Massachusetts delivery will include 5% sales tax. Please send information on exhibiting and opportunities to present workshops. PAYMENT INFORMATION Enclosed is a check or money order payable to Cambridge Healthtech Institute, drawn on a U.S. bank, in U.S. currency. Invoice me, but reserve my space with credit card information listed below. Invoices unpaid two weeks prior to conference will be billed to credit card at full registration rate. Invoices must be paid in full and checks received by the deadline date to retain registration discount. If you plan to register on site, please check with CHI beforehand for space availability. Please charge: AMEX (15 digits) Visa (13-16 digits) MasterCard (16 digits) Diners Club (14 digits) Card # Exp. Date Cardholder Signature Cardholder s Address (if different from above) City/State/Postal Code Country Please refer to the Keycode below: Yes! I would like to receive a FREE subscription to: a monthly magazine focused on technologies for the life sciences the premiere e-news source on technology for healthcare a weekly e-newsletter report on the technologies advancing clinical trials 838 F Present a Poster and Save $50! Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference CD, your abstract must be submitted, accepted and registration paid in full by January 23, Register online to use the Poster Abstract Submission form or, if you register by phone, fax, or mail, you will receive Poster Abstract Submission guidelines via . I am interested in presenting a poster at Transmissible Spongiform Encephalopathies and will submit a completed one-page abstract by January 23, 2008 (Please Note: Registration must be paid in full to present poster.) Title CHI insight Pharma Reports A series of reports that evaluate the salient trends in pharmaceutical technology, business, and therapy markets. Keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. For a list of reports, visit Insightpharma.com, or contact Rose LaRaia, rlaraia@healthech.com, Additional Registration Details Each registration includes all conference sessions, posters and exhibits, food functions, and a copy of the conference CD. Group Discounts Special rates are available for multiple attendees from the same organization. Contact David Cunningham at to discuss your options and take advantage of the savings. Handicapped Equal Access In accordance with the ADA, Cambridge Healthtech Institute is pleased to arrange special accommodations for attendees with special needs. All requests for such assistance must be submitted in writing to CHI at least 30 days prior to the start of the meeting. Substitution/Cancellation Policy In the event that you need to cancel a registration, you may: Transfer your registration to a colleague within your organization Credit your registration to another Cambridge Healthtech Institute program Request a refund minus a $100 processing fee per conference Request a refund minus the cost ($250) of ordering a copy of the CD NOTE: Cancellations will only be accepted up to two weeks prior to the conference. Program and speakers are subject to change. Video and or audio recording of any kind is prohibited onsite at all CHI events. Cambridge Healthtech Institute 250 First Avenue, Suite 300, Needham, Massachusetts T: or toll-free in the U.S F:
Prion Infectivity Removal from Human Plasma and Plasma Products Using Affinity Ligands
Plasma Product Biotechnology Meeting 2009 Menorca, Spain Prion Infectivity Removal from Human Plasma and Plasma Products Using Affinity Ligands L. Gregori, B. Lambert, 1 P.V. Gurgel, J. Lathrop, M. Behizad,
More informationBIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE
The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting
More informationPr oject Summar y. Development of a diagnostic assay for chronic wasting disease. Principal Investigator: Richard Rubenstein
Pr oject Summar y Development of a diagnostic assay for chronic wasting disease Principal Investigator: Richard Rubenstein New York State Institute for Basic Research Study Completed May 2003 Funded by
More informationPrions A Challenge and Informative Paradigm for the Cleaning and Disinfection of Medical Devices
Prions A Challenge and Informative Paradigm for the Cleaning and Disinfection of Medical Devices Annual WFHSS and JSMI Conference 2012 21-24 November 2012 Osaka, Japan Michael Beekes 1 Prion Diseases:
More informationPrion Removal Strategies: Challenges and Solutions
Prion Removal Strategies: Challenges and Solutions PV Gurgel, R Rohwer, RG Carbonell & SJ Burton* Pathogen Removal and Diagnostic Technologies Inc. (PRDT) Origin of vcjd Late 1970 s 1986 1990 1995 1996
More informationAward Number: DAMD Efficient and Rapid Development of Transgenic Hamster Models of TSE's Using a Radical New Technology TITLE:
AD Award Number: DAMD17-03-1-0746 TITLE: Efficient and Rapid Development of Transgenic Hamster Models of TSE's Using a Radical New Technology PRINCIPAL INVESTIGATOR: Robert G. Rohwer, Ph.D. Irena Alexeeva,
More informationDEVELOPMENT OF A DEVICE FOR REDUCTION OF PRION INFECTIVITY FROM RED BLOOD CELL CONCENTRATE
DEVELOPMENT OF A DEVICE FOR REDUCTION OF PRION INFECTIVITY FROM RED BLOOD CELL CONCENTRATE Patrick Gurgel XIX th Regional Congress of the ISBT WP TTID Annual Meeting March 2009 Pathogen Removal and Diagnostic
More information1997 Nobel Prize in Physiology or Medicine Dr. Stanley Prusiner
1997 Nobel Prize in Physiology or Medicine Dr. Stanley Prusiner for the discovery of prions* - a new biological principal of infection I. PRIONS - Definition Prions are simple proteins that are much smaller
More informationBaltimore Marriott Inner Harbor Baltimore, MD May 4-6, Exhibit Registration
Please join us as an exhibitor at the Dry Storage Information Forum. With an expected attendance of 175 used fuel specialists, this will be an excellent opportunity for any company in the industry. ion
More informationNUCLEAR ENERGY ASSEMBLY. June 3-5 Omni Shoreham Washington, D.C. SPONSORSHIP OPPORTUNITIES. nei.org/nea
NUCLEAR ENERGY ASSEMBLY June 3-5 Omni Shoreham Washington, D.C. 2019 SPONSORSHIP OPPORTUNITIES nei.org/nea A NEW MOMENTUM #NEA19 THE PREMIER EVENT OF THE NUCLEAR ENERGY INDUSTRY The Nuclear Energy Assembly
More information2018 ADAM Annual Meeting
2018 ADAM Annual Meeting Exhibitor & Partner Prospectus February 12-14, 2018 Exhibit Show February 13 San Diego, CA Exhibit Application Deadline: November 22, 2017 APPLY EARLY TO ENSURE A SPOT! ADAM is
More informationRESEARCH MEETING. Sponsor, Exhibitor & Advertiser Prospectus ANNUAL. June 24 26, 2018 Washington State Convention Center, Seattle, WA
ANNUAL RESEARCH MEETING TODAY S RESEARCH DRIVING TOMORROW S OUTCOMES 2018 Sponsor, Exhibitor & Advertiser Prospectus www.academyhealth.org/arm June 24 26, 2018 Washington State Convention Center, Seattle,
More informationSPONSORSHIP & EXHIBITION 2019
SPONSORSHIP & EXHIBITION 2019 Microbiology Congress 2019 Theme: Novel Innovations and Trends in Microbiology and Pathology 2 nd World Congress on MICROBIOLOGY AND CLINICAL PATHOLOGY May 21-22, 2019 Rome,
More informationConference Sponsorship & Exhibit Opportunities
Conference Sponsorship & Exhibit Opportunities October 22-25, 2018 Tampa Marriott Waterside Tampa, FL SPONSORSHIP OPPORTUNITIES Thank you for your interest in sponsorship. We hope you ll join us at the
More informationConference Sponsorship & Exhibit Opportunities
Conference Sponsorship & Exhibit Opportunities October 22-25, 2018 Tampa Marriott Waterside Tampa, FL SPONSORSHIP OPPORTUNITIES Thank you for your interest in sponsorship. We hope you ll join us at the
More informationAging and Metabolism
Aging and Metabolism September 23 25, 2018 Sitges, Spain Supporting Journals This meeting brings together scientists who have interests in aging, metabolism and immunology to explore the growing intersection
More informationNUCLEAR ENERGY ASSEMBLY SPONSORSHIP OPPORTUNITIES PREMIER EVENT OF THE NUCLEAR INDUSTRY MAY 21-23, 2018 ATLANTA MARRIOTT MARQUIS ATLANTA, GA
NUCLEAR ENERGY ASSEMBLY SPONSORSHIP OPPORTUNITIES PREMIER EVENT OF THE NUCLEAR INDUSTRY MAY 21-23, 2018 ATLANTA MARRIOTT MARQUIS ATLANTA, GA The annual Nuclear Energy Assembly and Supplier Expo brings
More informationCancer, Inflammation, and Immunity June 11 13, 2017 San Diego, CA, USA
Cancer, Inflammation, and Immunity June 11 13, 2017 San Diego, CA, USA Supporting Journals This symposium will bring together leading experts to discuss basic immunology, cancer-immune cell interactions,
More informationCorporate Sponsorship Program
The Maryland-National Capital Homecare Association (MNCHA) is the trade association for the home care sector in Maryland and Washington D.C., representing both non-profit and for-profit health care providers.
More informationChapter 1 Prion. 1.1 General overview of prion and prion diseases
Chapter 1 Prion 1.1 General overview of prion and prion diseases Scrapie is a prion agent. Prions are 'self-replicating' basic proteins of small molecular weight. Prions form a new class of infectious
More informationLUPAS Luminescent Polymers for in vivo Imaging of Amyloid Signatures
LUPAS Luminescent Polymers for in vivo Imaging of Amyloid Signatures A research project for innovative diagnostics for neurodegenerative disorders Funded by the European Union under the 7 th Framework
More informationClinical and Medical Microbiology
allied academies World Congress on Clinical and Medical Microbiology June 25-26, Theme: Exploring The Latest Research Advancements in the field of Clinical and Medical Microbiology Sponsorship June 25-26
More informationSearching for Custom Dominant Negative PrPs by In Vitro Prion Replication Studies
Searching for Custom Dominant Negative PrPs by In Vitro Prion Replication Studies Joaquín Castilla, PhD CJD 2010 and the CJD Foundation Family Conference July 2010 The problem Prion diseases are neurodegenerative
More informationallied Theme: Discover and Network : The Trends in Vaccines and Global Health Issues November 1-2, 2017 Toronto, Canada
allied academies Global Vaccines & Vaccination Summit and B2B November 1-2, 2017 Toronto, Canada Theme: Discover and Network : The Trends in Vaccines and Global Health Issues Dear Prospective Sponsor/Exhibitor,
More informationPrions Other molecules besides organelle DNA are inherited in non-mendelian patterns.
Prions Other molecules besides organelle DNA are inherited in non-mendelian patterns. Examples of non-mendelian patterns of inheritance extend beyond the inheritance of organelle DNA. Certain DNA and RNA
More informationSPONSORSHIP & EXHIBITION 2019
** CPD Accredited SPONSORSHIP & EXHIBITION 2019 Immunotherapy 2019 Theme: Blooming and Enhancing the Novel Approach in Immunology 2 nd Global Summit on IMMUNOLOGY AND CELL BIOLOGY May 22-23, 2019 Rome,
More informationPHARMACEUTICAL CHEMISTRY & DRUG DISCOVERY
SPONSORSHIP & EXHIBITION 2019 Pharma Chem Congress 2019 Theme: Transformative Experience on Pharmaceutical Chemistry and Drug Delivery 2 nd International Conference on PHARMACEUTICAL CHEMISTRY & DRUG DISCOVERY
More informationInvitation to Exhibit
Invitation to Exhibit Hyatt Hill Country, San Antonio NOVEMBER 11 12, 2017 Governor s Letter On behalf of our members, I invite you to participate in the 2017 Texas Chapter of the American College of Physicians
More informationallied Cell Science, Stem Cell Research & Regenerative Medicine Annual Congress on
allied academies Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine November 29-30, 2017 Atlanta, USA Theme: Modern Research and Developments in Cell Science, Stem Cell Research
More informationPHARMACEUTICAL CHEMISTRY & DRUG DISCOVERY
SPONSORSHIP & EXHIBITION 2019 Pharma Chem Congress 2019 Theme: Transformative Experience on Pharmaceutical Chemistry and Drug Delivery 2 nd International Conference on PHARMACEUTICAL CHEMISTRY & DRUG DISCOVERY
More informationManaging Projects. Strategies, Tools and Tactics for Effective Project Management June 5-6, 2008 Park Hyatt Philadelphia Hotel Philadelphia, PA
Final Agenda Fifth Annual Register by May 2 and Save up to $500! The Pharmaceutical Strategy Series Presents Managing Projects and Resources Strategies, Tools and Tactics for Effective Project Management
More informationSponsorship Application & Contract
Sponsorship Levels Sponsorships are based on availability All prices are listed in U.S. dollars. (US$). Platinum Sponsor US$1,500 Early Bird US$1,200 (Ends July 31) Guaranteed speaking opportunity on an
More informationGROWING OUR FOOD FUTURE
GROWING OUR FOOD FUTURE SPONSORSHIP PROSPECTUS PLATINUM PACKAGE INCLUSIONS Recognition as a Hort Connections Platinum Partner Priority access to Trade Show booth selection as a Platinum Partner 2 x Trade
More informationCell & Gene Therapy. Sponsorship. allied. September academies. International Conference on. September 10-11, 2018 Dublin, Ireland
allied academies YEARS IN INTERNATIONAL International Conference on Cell & Gene Therapy September 10-11, September 10-11 Theme: Exploring the possibilities in Cell & Gene Therapy Sponsorship For More Details
More informationILLINOIS PEST CONTROL ASSOCIATION SPRING 2018 CONFERENCE. February 26-27, Thelma Keller Convention Center, Effingham, IL
ILLINOIS PEST CONTROL ASSOCIATION SPRING 2018 CONFERENCE Thelma Keller Convention Center, Effingham, IL SCHEDULE OF EVENTS CEUS APPLIED FOR IN ILLINOIS AND INDIANA MONDAY, FEBRUARY 26 SEGMENT 1 1:00 PM
More informationJiali Li, Sukhvir P Mahal, Cheryl A Demczyk and Charles Weissmann
Manuscript EMBOR-2011-35144 Mutability of prions Jiali Li, Sukhvir P Mahal, Cheryl A Demczyk and Charles Weissmann Corresponding author: Charles Weissmann, Scripps Florida Review timeline: Submission date:
More informationAccelerated high fidelity prion amplification within and across prion species barriers
University of Kentucky UKnowledge Microbiology, Immunology, and Molecular Genetics Faculty Publications Microbiology, Immunology, and Molecular Genetics 8-29-2008 Accelerated high fidelity prion amplification
More informationAnnual Convention 2016 MMI. RESERVE NOW! Limited Space Available! Sponsor/Exhibitor Invitation & Prospectus
ADVANCING THE FUTURE OF INVESTMENT ADVISORY SOLUTIONS ADVANCING THE FUTURE OF INVESTMENT ADVISORY SOLUTIONS Sponsor/Exhibitor Invitation & Prospectus 2016 MMI Annual Convention April 20 21, 2016 Marriott
More informationEXHIBITOR PROSPECTUS
Texas Pediatric Society 2017 Annual Meeting EXHIBITOR PROSPECTUS October 5-6, 2017 Renaissance Dallas at Plano Legacy West Meeting Exhibit i e t i ng a l Me o n a l P 2017 A nnu West y c a g e L Exhibit
More informationSponsorship. allied. September Bangkok, Thailand. academies. International Conference on STD-AIDS and Infectious Diseases
allied academies International Conference on STD-AIDS and Infectious Diseases September 03-04, September 03-04 Theme: Making the Prevention Revolution Real - AIDS Sponsorship For More Details For Queries
More informationallied Annual Biotechnology Congress Theme: New Scientific Developments in Biotechnology of Modern Era August 17-18, 2017 Toronto, Canada academies
Annual Biotechnology Congress allied academies August 17-18, 2017 Toronto, Canada Theme: New Scientific Developments in Biotechnology of Modern Era Dear Prospective Sponsor/Exhibitor, Greetings from Biotechnology
More informationSPONSORSHIP & EXHIBITION 2019
SPONSORSHIP & EXHIBITION 2019 Euro Vaccines 2019 Theme: Focusing On Modern Challenges In Vaccine Design, Delivery, Research And Development 4 th International Conference on VACCINES AND IMMUNOLOGY January
More informationSPONSORSHIP OPPORTUNITIES
2018 ANNUAL 2018 ANNUAL SPONSORSHIP OPPORTUNITIES PMBA invites your organization to join PMBA for the 2018 Annual Conference in Long Beach, CA on, May 29- June 1, 2018. We invite you to join an elite group
More informationAnnual International Conference
The 209 Annual International Conference SEPTEMBER 22-25, 209 The Guesthouse at Graceland EXHIBITOR PROSPECTUS Why Should Your Company Exhibit at the 2019 Annual International Trade Show? This is the one
More informationIllinois formerly Life Services Network. OUR BIGGEST EVENT from the largest aging services association in Illinois.
SPONSORSHIP, EXHIBIT AND ADVERTISING OPPORTUNITIES This Way Forward 2015 Annual Meeting & Exhibition April 29 - May 1, 2015 Rosemont, IL OUR BIGGEST EVENT from the largest aging services association in
More informationNeuroscience and Neurological Disorders
Sponsorship & Exhibition Theme: Exploring Upcoming Knowledge of Neuro Researches International Conference on Neuroscience and Neurological Disorders June -9, Dublin, Ireland Dear Prospective Sponsor/Exhibitor,
More informationMAY 19-20, 2011
ANNUAL REVIEW Hospitals and Health Systems Leadership Conference ACOs, Physician Hospital Integration, Key Specialties and Improving Profits www.beckershospitalreview.com * * * MAY 19-20, 2011 P A L O
More informationPlasma Chemistry 2017
Sponsorship Plasma Chemistry Theme: An Ingenious Approach to Discover the Recent Developments and Advancements in the Field of Plasma Chemistry 5 th International Conference on Plasma Chemistry and Plasma
More informationNeuroscience and Neurological Disorders
Sponsorship & Exhibition Theme: Exploring Upcoming Knowledge of Neuro Researches International Conference on Neuroscience and Neurological Disorders June -9, Dublin, Ireland Dear Prospective Sponsor/Exhibitor,
More informationSPONSORSHIP & EXHIBIT OPPORTUNITIES
SPONSORSHIP & EHIBIT OPPORTUNITIES LESI 2018 ANNUAL CONFERENCE Strong IP Drives the Bottom Line April 29 May 2 l Manchester Grand Hyatt l San Diego,California Welcome to Our Sponsors and Exhibitors! LESI
More informationSPONSORSHIP OPPORTUNITIES JUNE 3 6, 2018 INCREASE YOUR BRAND RECOGNITION AND INCREASE BUSINESS
JUNE 3 6, 2018 SPONSORSHIP OPPORTUNITIES INCREASE YOUR BRAND RECOGNITION AND INCREASE BUSINESS Place your products and services in front of key decision makers Promote your organization to more than 1,800
More informationSponsors & Exhibitor Opportunities
#NCSEA14ACE PORTLAND, OR 2014 NCSEA Annual Conference & Expo Sponsors & Exhibitor Opportunities Over 600 professionals in the child support community will convene in Portland this August to explore, innovate,
More informationClinical Pharmacy 2017
Sponsorship Clinical Pharmacy Theme: Education, Development and Embodying the Principles of Clinical Pharmacy: For Future Success th World Congress on Clinical Pharmacy and Pharmacy Practice December -9,
More informationGlobal Pharma Summit
allied academies Global Pharma Summit September 03-04, September 03-04 Theme: Advanced Pharma Technologies-Better Healthcare system Sponsorship For More Details For Queries pharmaceutical@alliedmeetings.com
More informationCancer Therapy and Oncology
Sponsorship Cancer Summit Theme: Eliminating Cancer Through Prevention and Innovation: Multidisciplinary Approach International Conference on Cancer Therapy and Oncology June -, Osaka, Japan Cancer Summit
More informationClinical Practice Compliance Conference (formerly known as the Physician Practice/Clinic Compliance Conference*)
EXHIBITOR/SPONSORSHIP PROSPECTUS Clinical Practice Compliance Conference (formerly known as the Physician Practice/Clinic Compliance Conference*) OCTOBER 14 16, 2012 Philadelphia, PA DoubleTree by Hilton
More informationClinical Diabetes 2017
Clinical Diabetes Sponsorship Theme: Diabetes Management address improvements in Current Therapeutics 6 th International Conference on Clinical Diabetes December 4-5, Rome, Italy Clinical Diabetes http://diabetes..com/
More informationSponsorship Opportunities
2017 National Meeting Sponsorship Opportunities NATIONAL ASSOCIATION OF MAY 3-6, 2017 - BOSTON MARRIOTT COPLEY PLACE - BOSTON, MASS. SPONSORSHIP DEADLINE: JANUARY 20, 2017 For more information, please
More informationRESEARCH MEETING SPONSOR, EXHIBITOR, AND ADVERTISER PROSPECTUS ANNUAL TODAY S RESEARCH DRIVING TOMORROW S OUTCOMES. June academyhealth.
ANNUAL RESEARCH MEETING TODAY S RESEARCH DRIVING TOMORROW S OUTCOMES Hyatt Regency New Orleans June 25 27 2017 SPONSOR, EXHIBITOR, AND ADVERTISER PROSPECTUS academyhealth.org/arm Hyatt Regency New Orleans
More information5 TH WORLD VACCINES AND IMMUNOLOGY CONGRESS
SPONSORSHIP & EXHIBITION 2019 Vaccines Congress 2019 Theme: Promulgate a vision in the field of vaccines and immunology 5 TH WORLD VACCINES AND IMMUNOLOGY CONGRESS June 10-11, 2019 Bangkok, Thailand http://vaccinescongress./
More informationNEUROSCIENCE AND NEUROLOGICAL DISORDERS
SPONSORSHIP & EXHIBITION 2019 Neuroscience Congress 2019 Theme: Collaborating the Building Blocks of Neuroscience and Psychiatric Experts 2 nd International Conference on NEUROSCIENCE AND NEUROLOGICAL
More informationSPONSORSHIP & EXHIBITION OPPORTUNITIES
SPONSORSHIP & EHIBITION OPPORTUNITIES LESI 2018 ANNUAL CONFERENCE Strong IP Drives the Bottom Line April 29 May 2 Manchester Grand Hyatt San Diego,California l l Welcome to Our Sponsors and Exhibitors!
More informationSponsorship. Pharmaceutical Analytical Chemistry & Technology. allied. June academies. International Conference on
allied academies International Conference on Pharmaceutical Analytical Chemistry & Technology June 28-29, Theme: Exploring the Recent Trends & Advances in the Field of Pharma and Chemistry June 28-29 Sponsorship
More informationMarch 16 19, 2014 Coronado Island Marriott Resort and Spa, Coronado, CA. Sponsor Prospectus
4th International Conference on Stem Cell Engineering March 16 19, 2014 Coronado Island Marriott Resort and Spa, Coronado, CA. Sponsor Prospectus The Conference The 4th International Conference on Stem
More informationSPONSORSHIP. Educational Conference. & Expo. 34th Annual National. OCTOBER 5-7, 2014 J.W. Marriott Desert Ridge Resort & Spa Phoenix, AZ
34th Annual National Educational Conference & Expo OCTOBER 5-7, 2014 J.W. Marriott Desert Ridge Resort & Spa Phoenix, AZ SPONSORSHIP www.siia.org OPPORTUNITIES 800.851.7789 SPONSORSHIPS 1700 ATTENDEES
More informationSpring Conference May 4 & 5, 2018
MANA 2018 Spring Conference May 4 & 5, 2018 MOTORCITY CASINO HOTEL Downtown Detroit EXHIBITOR PROSPECTUS The Michigan Association of Nurse Anesthetists invites you to participate in the MANA Spring 2018
More informationSponsorship and Exhibit Opportunities Included With Sponsorships
2018 Annual Statewide Conference April 22 25, 2018 at the Penn Stater Hotel, State College, PA ship and Exhibit Opportunities Included With ships Up to four complimentary full-conference Up to three complimentary
More informationNeurology and Brain Disorders
Cancer Stem Cells 7 Sponsorship & Exhibition Theme: World of Opportunities at neurology International conference on Neurology and Brain Disorders June -, Osaka, Japan Dear Prospective Sponsor/Exhibitor,
More informationNFPA CONFERENCE & EXPO MARKETING OPPORTUNITIES
NFPA & MARKETING OPPORTUNITIES and LOW Cost Marketing Opportunities Marketing your participation is crucial to helping you have a successful NFPA Conference & Expo experience. We encourage you to take
More informationSPONSORSHIP OPPORTUNITIES
2017 ANNUAL 2017 ANNUAL SPONSORSHIP OPPORTUNITIES PMBA invites your organization to join us for the 2017 Annual Conference in St. Louis, MO on. Get yourself in front an elite group of public media professionals
More informationProgress in detecting prions and diagnosing prion diseases. Byron Caughey TSE/Prion Biochemistry Section, LPVD, Rocky Mountain Labs
Progress in detecting prions and diagnosing prion diseases Byron Caughey TSE/Prion Biochemistry Section, LPVD, Rocky Mountain Labs Amyloid plaque Pam Caughey Transmissible spongiform encephalopathies (prion)
More informationSince 1984, the National Association of Government Guaranteed Lenders (NAGGL)
12018 Conference NAGGL Gets 2018 CONFERENCES SBA Lending Technical Conference May 1-3 Chicago, IL Annual Conference November 13-15 San Diego, CA Invitation to Sponsors The National Gathering of Your Target
More informationORGANIC AND INORGANIC CHEMISTRY SPONSORSHIP & EXHIBITION nd International Conference on. July 22-23, 2019 Brussels, Belgium
SPONSORSHIP & EXHIBITION 2019 Organic Chemistry 2019 Theme: Innovations And Emerging Novel Research In Organic And Inorganic Chemistry 2 nd International Conference on ORGANIC AND INORGANIC CHEMISTRY July
More informationTITLE: Development of an Assay for the Detection of PrPres in Blood and Urine Based on PMCA Assay and ELISA Methods
AD Award Number: DAMD17-3-1-756 TITLE: Development of an Assay for the Detection of PrPres in Blood and Urine Based on PMCA Assay and ELISA Methods PRINCIPAL INVESTIGATOR: Robert G. Rohwer, Ph.D. Luisa
More informationSince 1984, the National Association of Government Guaranteed Lenders (NAGGL)
12018 Conference NAGGL Gets 2018 CONFERENCES November 13-15 San Diego, CA Invitation to Sponsors The National Gathering of Your Target Market Leaders of the SBA 7(a) Lending Industry Since 1984, the National
More informationNiagaraFalls' CSSE. september. SPONSOR & EXHIBITOR GUIDE Scotiabank Convention Centre, Niagara Falls, ON PROFESSIONAL DEVELOPMENT CONFERENCE
CSSE NiagaraFalls'8 PROFESSIONAL DEVELOPMENT CONFERENCE september 6-9 208 SPONSOR & EXHIBITOR GUIDE Scotiabank Convention Centre, Niagara Falls, ON PLATINUM $5,000 Opening Keynote, Closing Keynote or Sponsor
More informationSponsorship Information 2014 Global Real Estate Markets Conference New York Stock Exchange November 14, 2014
Sponsorship Information 2014 Global Real Estate Markets Conference New York Stock Exchange November 14, 2014 The James A. Graaskamp Center for Real Estate at the Wisconsin School of Business and Toll Brothers
More informationTHE NATIONAL CONFERENCE OF THE FOUNDATON FIGHTING BLINDNESS SPONSOR. EXHIBIT. ADVERTISE.
THE NATIONAL CONFERENCE OF THE FOUNDATON FIGHTING BLINDNESS SPONSOR. EXHIBIT. ADVERTISE. www.fightblindness.org/visions THE NATIONAL CONFERENCE OF THE FOUNDATION FIGHTING BLINDNESS JUNE 25-27, 2015 BALTIMORE
More informationBRISBANE 2019 SPEAKERS IMMUNOTHERAPY SPONSOR PROSPECTUS May. Brisbane Convention and Exhibition Centre, Australia. Professor Marco Colonna
BRISBANE IMMUNOTHERAPY Brisbane Convention and Exhibition Centre, Australia 23-25 May SPONSOR PROSPECTUS 2019 SPEAKERS Professor Stephen Gottschalk Professor Marco Colonna Department of Bone Marrow Transplantation
More informationNeurology and Brain Disorders
Cancer Stem Cells 7 Sponsorship & Exhibition Theme: World of Opportunities at neurology International conference on Neurology and Brain Disorders June -, Osaka, Japan Neurocongress Dear Prospective Sponsor/Exhibitor,
More informationExhibitor and Sponsorship Prospectus
Wilson Cardiology Update Saturday, September 16, 2017 Exhibitor and Sponsorship Prospectus wilson cardiology update exhibitor and sponsorship prospectus 1 Conference Overview The Wilson Cardiology Update
More informationThe Power of Relationships
2019 Sponsorship Opportunities The Power of Relationships Sponsorship Advantages Join us July 22-24, 2019 for the 56 th Annual Convention and Exposition at the Hilton Bonnet Creek. The other events in
More informationP H O T O P U B L I S H I N G S U M M I T
A Questex Company P H O T O P U B L I S H I N G S U M M I T Turning Images into New Revenue Streams Sponsorship Opportunities October 14-15, 2008 Sheraton Gateway Burlingame, CA The Premier Meeting Summit
More informationIMMUNOTHERAPY 2008: IMPLEMENTING COMBINATIONS
8 th International Workshop IMMUNOTHERAPY 2008: IMPLEMENTING COMBINATIONS Organized by: International Union Against Cancer (UICC) Center of Molecular Immunology Cuba, November 10-14, 2008 (http://www.uicc.org)
More informationParadise Found: exhibitor & Sponsorship Information. May 8-11, Paradise Point, San Diego, CA wcisaconnect.com. Plans, partners, Progress
Paradise Found: Plans, partners, Progress Arboriculture for tomorrow exhibitor & Sponsorship Information May 8-11, 2017 wcisaconnect.com Paradise Found Exhibitor Information The opportunities for exposure
More information62ND ANNUAL IAPD CONVENTION SPONSORSHIP MEDIA/DIGITAL OPPORTUNITIES OCTOBER 1-4, 2018
62ND ANNUAL IAPD CONVENTION SPONSORSHIP MEDIA/DIGITAL OPPORTUNITIES OCTOBER 1-4, 2018 GENERATE MOMENTUM BUILD YOUR BRAND ATTRACT NEW CUSTOMERS! TO RESERVE A SPONSORSHIP OR FOR MORE INFORMATION, CONTACT
More informationBUILDING STRATEGY MAPS AND SCORECARDS IN UTILITIES
BUILDING STRATEGY MAPS AND SCORECARDS IN UTILITIES COURSE September 25-26, 2017 Baltimore Marriott Inner Harbor at Camden Yards Baltimore, MD TAG US #EUCIEvents FOLLOW US @EUCIEvents SPONSOR EUCI is authorized
More informationSleep Disorders and Medicine
3rd International Conference on Sleep Disorders and Medicine allied academies October 24-25, 2018 Toronto, Ontario, Canada Theme: Challenges of Sleep Disorders and Treatment by Advanced Sleep Therapy Dear
More informationVaccine Congress 2017
Sponsorship Vaccine Congress Theme: A Global Discussion on technologies, advances and challenges in Vaccines 9 th International Vaccine Congress and BB Meeting October 3-3, Chicago, USA Dear Prospective
More informationVaccines and Vaccination
allied academies YEARS IN INTERNATIONAL 3 rd Global Congress on Vaccines and Vaccination November 14-15, Rome, Italy Theme: Trending New Challenges and Emerging Technologies in Vaccines and Vaccination
More informationBacteriology. allied. Theme: Annunciate Research frontiers in Bacteriology. 5th World Congress on. October 16-17, 2017 Rome,Italy.
5th World Congress on Bacteriology allied academies October 16-17, 2017 Rome,Italy Theme: Annunciate Research frontiers in Bacteriology Dear Prospective Sponsor/Exhibitor, Greetings from Bacteriology Congress
More informationCONFERENCE SPONSORSHIPS
CONFERENCE SPONSORSHIPS THE MOST POWERFUL PEOPLE IN FOODSERVICE CONNECT HERE. YOUR BRAND AND PRODUCTS SHOULD BE HERE TOO. Join fellow foodservice leaders at the 2017 IFMA Presidents. This premier senior
More informationEuro Green Chemistry 2017
Sponsorship Euro Green Chemistry Theme: Recent Innovations and Concerns of Green Chemistry towards Sustainability 5 th International Conference on Green Chemistry and Technology July 4-6, Rome, Italy Dear
More informationSPONSORSHIP & EXHIBITION 2019
SPONSORSHIP & EXHIBITION 2019 Chemistry 2019 Theme: Recent Research in Chemistry & Exploring Pathways towards Drug Designingt 9 th International Conference on CHEMISTRY AND DRUG DESIGN May 20-21, 2019
More information2 nd International Meeting on Fire Safety and Emergency Preparedness for the Nuclear Industry
2 nd International Meeting on Fire Safety and Emergency Preparedness for the Nuclear Industry (FSEP 2017) Sponsorship Packages September 17-20, 2017 Toronto Marriott Downtown Eaton Centre Hotel, Ontario,
More informationICH CONSIDERATIONS Oncolytic Viruses
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ICH CONSIDERATIONS Oncolytic Viruses 20 November 2008 EMEA/CHMP/GTWP/607698/2008
More information2019 APMM Annual Conference
2019 APMM Annual Conference May 14-16 EXHIBITOR, SPONSORSHIP AND ADVERTISING INFORMATION www.apmm.net 2019 APMM Annual Conference December 17, 2018 Dear Potential Sponsors, Advertisers, Exhibitors and
More informationSPONSORSHIP. OPPORTUNITIES.
SPONSORSHIP. OPPORTUNITIES. the leading event for public risk professionals JUNE 9 12 2019 INCREASE YOUR BRAND RECOGNITION AND INCREASE BUSINESS Place your products and services in front of key decision
More informationgastroenterology and endoscopy
allied academies world congress on gastroenterology and endoscopy October 30-31 2017 Toronto,Canada Theme: Trowel the differentiated effects and bleeding edge advancements of Gastroenterology and Endoscopy
More informationICH Considerations. Oncolytic Viruses September 17, 2009
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations Oncolytic Viruses September 17, 2009 1. Introduction Oncolytic viruses
More information